Malignant Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate [Phase 2]
A Phase 2 trial evaluating extrapleural pneumonectomy with intraoperative heated cisplatin plus amifostine and sodium thiosulfate for malign…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma [Phase 1]
Phase 1 trial evaluating dendritic cell–based immunotherapy in combination with low-dose cyclophosphamide for malignant pleural mesothelioma…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating sunitinib in advanced or recurrent malignant pleural mesothelioma has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Pazopanib in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]
A Phase 2 clinical trial evaluating Pazopanib for malignant pleural mesothelioma has completed, with results posted in 2013.
-
FDA approval · 2013-09-12FDA Approved: ALIMTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ALIMTA (pemetrexed disodium) submitted by Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma [Phase 3]
Phase 3 trial comparing active symptom control with or without chemotherapy in malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS withdrawal · 2013-08-02Clinical Trial Update: AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating AMG 102 in combination with pemetrexed disodium and cisplatin for malignant pleural mesothelioma has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery [Phase 3]
Phase 3 trial evaluating cisplatin with or without pemetrexed disodium in patients with unresectable malignant pleural mesothelioma. The stu…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma [Phase 1]
A Phase 1 clinical trial evaluating the combination of cisplatin, interferon alfa, surgery, and radiation therapy for malignant pleural meso…
-
FDA approval · 2013-03-13FDA Approved: ALIMTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ALIMTA (pemetrexed disodium) from Eli Lilly and Company, updating its labeling with addition…
-
CLINICAL_TRIALS research · 2013-03-12Clinical Trial Update: A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma [Phase 2]
Phase II trial update evaluating TroVax in combination with chemotherapy for malignant pleural mesothelioma.
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial evaluated gemcitabine plus cisplatin for unresectable malignant pleural mesothelioma; the study is completed.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]
This Phase 2 trial evaluated pemetrexed disodium and cisplatin followed by surgery and radiation therapy for malignant pleural mesothelioma …
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung [Phase 2]
Phase 2 trial evaluating preoperative combination chemotherapy for malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS withdrawal · 2012-03-22Clinical Trial Update: A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
This clinical trial update reports the withdrawal of a Phase I/II study evaluating vorinostat added to pemetrexed-cisplatin as first-line th…
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update evaluating first-line treatment of malignant pleural mesothelioma with a carboplatin, bevacizumab,…
-
FDA approval · 2011-11-18FDA Approved: ALIMTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ALIMTA (pemetrexed disodium) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2011-10-31Clinical Trial Update: Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma [Phase 2]
Phase 2 trial evaluating Velcade (bortezomib) and Eloxatin (oxaliplatin) for malignant pleural or peritoneal mesothelioma. The current statu…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma [Phase 2]
Phase II trial evaluating bevacizumab with pemetrexed and carboplatin as first-line therapy for malignant pleural mesothelioma has completed…
-
CLINICAL_TRIALS research · 2011-04-28Clinical Trial Update: Trimodality Therapy for Malignant Pleural Mesothelioma
A clinical trial update on trimodality therapy for malignant pleural mesothelioma (NCT01343264) sponsored by HSK Wiesbaden; the current stat…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating the liposomal cisplatin analogue L-NDDP in malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment [Phase 2]
A Phase 2 trial evaluating long-infusion gemcitabine with cisplatin in malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Dendritic Cell-based Immunotherapy in Mesothelioma [Phase 1]
A Phase 1 clinical trial evaluating dendritic cell-based immunotherapy for malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-04Clinical Trial Update: Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial studying pemetrexed with gemcitabine or with carboplatin in advanced malignant pleural mesothelioma has completed with posted …
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma [Phase 2]
A phase 2 trial evaluating the combination of carboplatin and vinorelbine in malignant pleural mesothelioma has completed.